DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,157,553 | -78.3% | 4,666 | -79.0% | 0.05% | -75.8% |
| Q2 2023 | $5,333,635 | +1.7% | 22,223 | +6.8% | 0.19% | +1.0% |
| Q1 2023 | $5,245,836 | -3.2% | 20,814 | +1.9% | 0.19% | -9.4% |
| Q4 2022 | $5,421,475 | +2.6% | 20,426 | -0.2% | 0.21% | -9.8% |
| Q3 2022 | $5,284,000 | +1.9% | 20,458 | +0.0% | 0.24% | +8.3% |
| Q2 2022 | $5,186,000 | -14.0% | 20,457 | -0.5% | 0.22% | +3.3% |
| Q1 2022 | $6,028,000 | -5.8% | 20,551 | +5.7% | 0.21% | -2.3% |
| Q4 2021 | $6,399,000 | -1.4% | 19,450 | -8.7% | 0.22% | -10.4% |
| Q3 2021 | $6,489,000 | +25.0% | 21,315 | +10.2% | 0.24% | +6.7% |
| Q2 2021 | $5,192,000 | +17.7% | 19,347 | -1.3% | 0.22% | -3.0% |
| Q1 2021 | $4,413,000 | -0.8% | 19,609 | -2.0% | 0.23% | -9.0% |
| Q4 2020 | $4,447,000 | +1.4% | 20,016 | -1.8% | 0.26% | -8.9% |
| Q3 2020 | $4,386,000 | +24.7% | 20,389 | +2.6% | 0.28% | +13.8% |
| Q2 2020 | $3,516,000 | +27.1% | 19,878 | -0.6% | 0.25% | +8.8% |
| Q1 2020 | $2,767,000 | -10.6% | 19,990 | -0.9% | 0.23% | +9.2% |
| Q4 2019 | $3,096,000 | +6.9% | 20,170 | +0.6% | 0.21% | -1.0% |
| Q3 2019 | $2,896,000 | +1.7% | 20,048 | +0.6% | 0.21% | 0.0% |
| Q2 2019 | $2,848,000 | +7.4% | 19,927 | -0.8% | 0.21% | +7.2% |
| Q1 2019 | $2,651,000 | +26.2% | 20,083 | -1.4% | 0.20% | +2.1% |
| Q4 2018 | $2,100,000 | -3.0% | 20,364 | +2.2% | 0.19% | +11.7% |
| Q3 2018 | $2,165,000 | +10.0% | 19,925 | -0.1% | 0.17% | +3.6% |
| Q2 2018 | $1,968,000 | -3.9% | 19,942 | -4.6% | 0.16% | -4.1% |
| Q1 2018 | $2,048,000 | +8.1% | 20,911 | +2.4% | 0.17% | +12.4% |
| Q4 2017 | $1,895,000 | -2.4% | 20,420 | -9.7% | 0.15% | -7.8% |
| Q3 2017 | $1,941,000 | -77.1% | 22,620 | -77.5% | 0.17% | -77.9% |
| Q2 2017 | $8,494,000 | -3.4% | 100,646 | -2.1% | 0.75% | -3.5% |
| Q1 2017 | $8,791,000 | +23.8% | 102,785 | +12.6% | 0.78% | +13.2% |
| Q4 2016 | $7,102,000 | -6.1% | 91,246 | -5.5% | 0.69% | -4.1% |
| Q3 2016 | $7,566,000 | -39.9% | 96,521 | -22.6% | 0.72% | -40.8% |
| Q2 2016 | $12,598,000 | +4.8% | 124,734 | -1.5% | 1.21% | +4.8% |
| Q1 2016 | $12,017,000 | +1.0% | 126,679 | +2.2% | 1.16% | +2.0% |
| Q4 2015 | $11,896,000 | – | 123,929 | – | 1.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |